Tag Archives: The Stem Cell Blog

The top 10 CRISPR patent assignees at the world’s big five issuing agencies revealed – IAM (blog)

Continue reading

2018-05-10 NEWS

IAM (blog)

The top 10 CRISPR patent assignees at the world’s big five issuing agencies revealed
IAM (blog)
The USPTO is the most willing of the major patent offices to grant CRISPR-related patents, but activity in the field is increasing most rapidly in Asia, new research commissioned for IAM reveals. Earlier this year, iRunway produced a report on the
CRISPR dust-up; compulsory licensing in China; Novartis CEO wants US reform, and more April’s Life Sciences IP …Lexology

all 2 news articles »

Continue reading

2018-05-10 NEWS

IAM (blog)

The top 10 CRISPR patent assignees at the world’s big five issuing agencies revealed
IAM (blog)
The USPTO is the most willing of the major patent offices to grant CRISPR-related patents, but activity in the field is increasing most rapidly in Asia, new research commissioned for IAM reveals. Earlier this year, iRunway produced a report on the
CRISPR dust-up; compulsory licensing in China; Novartis CEO …Lexology

all 2 news articles »

Continue reading

2018-05-10 NEWS

Wall Street Journal

Eli Lilly Buys Immunotherapy Cancer Treatment Company for $1.6 Billion
Wall Street Journal
Immunotherapy, or immune-cell therapy, describes a range of treatments that harness a patient’s own immune system to target cancer. The approach doesn’t work in all patients, but has worked well against hard-to-treat cancers in some and has become the …
Eli Lilly acquires small biotech for $1.6B to strengthen cancer immunotherapy pipelineSTAT
Lilly (LLY) to Acquire ARMO BioSciences (ARMO) for $50/ShareStreetInsider.com

all 28 news articles »

Continue reading

2018-05-10 NEWS

Healthline

Stem Cell Treatments Provide Hope for Easing Back Pain
Healthline
Now the 78-year-old is touting an experimental stem cell surgery that he says is more effective than anything else he’s tried. The surgery, under the guidance of German scientist and physician Eckhard Alt, was performed two years ago in Munich. The